Skip to content
10-Q/A

Quarterly Report

Stemcell Holdings, Inc.

0001599916-17-000033

← back to feed
Filed
Dec 8, 2017 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Dec 8, 2017 27.6M sh
Operating Cash Flow Q2 2017 · Jun 30, 2017 $367
Operating Cash Flow Q2 2017 · Jun 30, 2016 $67.76K
Cash And Equivalents Q2 2017 · Jun 30, 2017 $4.54M
Cash And Equivalents Q2 2017 · Dec 31, 2016 $2.65M
Stockholders Equity restated Q2 2017 · Jun 30, 2017 $2.58M
Stockholders Equity Q2 2017 · Dec 31, 2016 $1.36M
Current Liabilities restated Q2 2017 · Jun 30, 2017 $3.13M
Current Liabilities Q2 2017 · Dec 31, 2016 $1.87M
Total Liabilities restated Q2 2017 · Jun 30, 2017 $3.13M
Total Liabilities Q2 2017 · Dec 31, 2016 $1.87M
Current Assets Q2 2017 · Jun 30, 2017 $4.89M
Current Assets Q2 2017 · Dec 31, 2016 $2.68M
Total Assets Q2 2017 · Jun 30, 2017 $5.71M
Total Assets Q2 2017 · Dec 31, 2016 $3.23M
Net Income restated Q2 2017 · Jun 30, 2017 $1.17M
Net Income Q2 2017 · Jun 30, 2016 $193.97K
Gross Profit Q2 2017 · Jun 30, 2017 $1.72M
Gross Profit Q2 2017 · Jun 30, 2017 $2.59M
Gross Profit Q2 2017 · Jun 30, 2016 $352.57K
Gross Profit Q2 2017 · Jun 30, 2016 $352.57K
Cost Of Revenue Q2 2017 · Jun 30, 2017 $372.84K
Cost Of Revenue Q2 2017 · Jun 30, 2017 $548.44K